News Focus
News Focus
icon url

Grip it and Sip It

10/19/22 9:55 AM

#523131 RE: CrashOverride #523130

I'm holding my shares too....it doesn't mean an investor can't be unhappy with some management decisions.

One fact remains clear: Linda Powers has NEVER brought a drug to approval. This is a very meticulous process that requires extreme precision and expertise. The market is just not that into her right now.

The only proof I need is the ultimate scorecard: the stock is $.67 after data was revealed at ASCO. Does Tom Brady get the win if he throws for more yards Josh Allen if the Bills win the game? There's no participation trophies here. Just results.
icon url

underpar71

10/19/22 9:56 AM

#523133 RE: CrashOverride #523130

That's a stretch of faith...
Landmark Trial Results! - We won't know until all the data is released and peer reviewed.
MHRA Trial Endorsement (PIP)! It's not an endorsement, it's an approval of the structure and baselines. Nothing to do with P3
Innovative Manufacturing! With no product, but spending on manufacturing anyway
Global Patent Protection! data and patents are the only current value.
icon url

Grip it and Sip It

10/19/22 11:18 AM

#523145 RE: CrashOverride #523130

I hope you get there. My group of buddies including myself have about the same amount. I was first in at $.30 and bought some on way up, so average is about $.65-.70.

Some of the others are $1.00 or so. But today, those 400k shares are worth about $255k….a galaxy away from $30m. There’s no panic. Just frustration. If this literally takes another few years, one would be best to sell asap because there is a BIG problem. We have the data! What could possibly take three years?
icon url

erik007tc

10/19/22 12:10 PM

#523162 RE: CrashOverride #523130

Great post!